These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22375924)

  • 1. The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.
    Rosin G; Hannelius U; Lindström L; Hall P; Bergh J; Hartman J; Kere J
    BMC Cancer; 2012 Feb; 12():79. PubMed ID: 22375924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancer.
    Chen Y; Zhao M; Wang S; Chen J; Wang Y; Cao Q; Zhou W; Liu J; Xu Z; Tong G; Li J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1265-76. PubMed ID: 19277710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
    Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
    J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular networks of DYX1C1 gene show connection to neuronal migration genes and cytoskeletal proteins.
    Tammimies K; Vitezic M; Matsson H; Le Guyader S; Bürglin TR; Ohman T; Strömblad S; Daub CO; Nyman TA; Kere J; Tapia-Páez I
    Biol Psychiatry; 2013 Mar; 73(6):583-90. PubMed ID: 23036959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs3743205 SNP is important for the regulation of the dyslexia candidate gene DYX1C1 by estrogen receptor β and DNA methylation.
    Tammimies K; Tapia-Páez I; Rüegg J; Rosin G; Kere J; Gustafsson JÅ; Nalvarte I
    Mol Endocrinol; 2012 Apr; 26(4):619-29. PubMed ID: 22383464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia.
    Massinen S; Tammimies K; Tapia-Páez I; Matsson H; Hokkanen ME; Söderberg O; Landegren U; Castrén E; Gustafsson JA; Treuter E; Kere J
    Hum Mol Genet; 2009 Aug; 18(15):2802-12. PubMed ID: 19423554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.
    BenAyed-Guerfali D; Dabbèche-Bouricha E; Ayadi W; Trifa F; Charfi S; Khabir A; Sellami-Boudawara T; Mokdad-Gargouri R
    Mol Biol Rep; 2019 Jun; 46(3):3247-3255. PubMed ID: 30941644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
    Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
    Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
    Guo J; Gong G; Zhang B
    Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia.
    Tapia-Páez I; Tammimies K; Massinen S; Roy AL; Kere J
    FASEB J; 2008 Aug; 22(8):3001-9. PubMed ID: 18445785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.